The Patent Finder

Crystalline Forms of Dimethoxy Docetaxel and Methods for Preparing the Same

Aventis Pharma S.A.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/FR2009/000042, filed Jan 15, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,378,128Crystalline Forms of Dimethoxy Docetaxel and Methods for Preparing the Same
In force
 · High confidence
Aventis Pharma S.A.In force
High confidence
US 10,160,739Crystalline Forms of Dimethoxy Docetaxel and Methods for Preparing the Same
In force
 · High confidence
Aventis Pharma S.A.In force
High confidence
US 8,846,959Crystalline Forms of Dimethoxy Docetaxel and Methods for Preparing the Same
Lapsed Sep 30, 2026 on the fee record
Ended Sep 30, 2026 · Medium confidence
Aventis Pharma S.A.Lapsed Sep 30, 2026 on the fee recordEnded Sep 30, 2026
Medium confidence
Application 14/453,087Crystalline Forms of Dimethoxy Docetaxel and Methods for Preparing the Same
Abandoned
Abandoned Jul 13, 2017
Aventis Pharma S.A.AbandonedAbandoned Jul 13, 2017
Application 16/188,687Crystalline Forms of Dimethoxy Docetaxel and Methods for Preparing the Same
Abandoned
Abandoned Jun 9, 2020
Aventis Pharma S.A.AbandonedAbandoned Jun 9, 2020
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Aventis Pharma S.A..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited